VERTEX PHARMACEUTICALS INC / MA: capex
| Value | {"amount": 120763000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | superseded |
| Entity | VERTEX PHARMACEUTICALS INC / MA |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/550c540e-593c-44d9-b1e1-8004a30e6eb8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000875320-21-000027Retrieved: 2026-08-19T08:42:23.584083+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000875320/capex/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/550c540e-593c-44d9-b1e1-8004a30e6eb8
History
- no predecessors — first report